SWARM ONCOLOGY LIMITED

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers

Active 6

1
Freund, Colin
Born in February 1970
Individual (3 offsprings)
Officer
2023-10-12 ~ now
OF - Director → CIF 0
2
Forte, Miguel, Dr
Born in December 1959
Individual (2 offsprings)
Officer
2024-01-29 ~ now
OF - Director → CIF 0
3
Olin, Martin
Born in May 1969
Individual (1 offspring)
Officer
2024-12-12 ~ now
OF - Director → CIF 0
4
Mr Igor Linshits
Born in December 1963
Individual (17 offsprings)
Person with significant control
2022-09-23 ~ now
PE - Has significant influence or control → CIF 0
5
Ekaterina Linshits
Born in September 1987
Individual (8 offsprings)
Person with significant control
2025-06-02 ~ now
PE - Has significant influence or control → CIF 0
6
Hay, Jonathan Russell
Born in September 1961
Individual (8 offsprings)
Officer
2023-02-09 ~ now
OF - Director → CIF 0

Ceased 3

1
Osherovich, Lev
Director born in September 1975
Individual (1 offspring)
Officer
2023-02-09 ~ 2023-10-06
OF - Director → CIF 0
2
Sims, Colin Howard
Director born in July 1969
Individual (1 offspring)
Officer
2022-09-23 ~ 2023-10-06
OF - Director → CIF 0
3
Ungar, Marshal
Chief Operating Officer born in January 1973
Individual
Officer
2022-09-23 ~ 2023-02-09
OF - Director → CIF 0

Company in focus

Standard Industrial Classification

72110 - Research And Experimental Development On Biotechnology

Brief company account

Par Value of Share

Class 1 ordinary share

02023-10-01 ~ 2024-09-30

Class 2 ordinary share

02023-10-01 ~ 2024-09-30

Property, Plant & Equipment

207,812 GBP2024-09-30

128,342 GBP2023-09-30

Debtors

288,103 GBP2024-09-30

176,368 GBP2023-09-30

Cash at bank and in hand

669,141 GBP2024-09-30

1,945,311 GBP2023-09-30

Current Assets

957,244 GBP2024-09-30

2,121,679 GBP2023-09-30

Creditors

Current

333,491 GBP2024-09-30

154,325 GBP2023-09-30

Net Current Assets/Liabilities

623,753 GBP2024-09-30

1,967,354 GBP2023-09-30

Total Assets Less Current Liabilities

831,565 GBP2024-09-30

2,095,696 GBP2023-09-30

Creditors

Non-current

3,147,619 GBP2024-09-30

2,918,141 GBP2023-09-30

Net Assets/Liabilities

-2,316,054 GBP2024-09-30

-822,445 GBP2023-09-30

Equity

Called up share capital

8 GBP2024-09-30

8 GBP2023-09-30

Retained earnings (accumulated losses)

-2,648,305 GBP2024-09-30

-1,140,770 GBP2023-09-30

Equity

-2,316,054 GBP2024-09-30

-822,445 GBP2023-09-30

Average Number of Employees

22023-10-01 ~ 2024-09-30

12022-09-23 ~ 2023-09-30

Property, Plant & Equipment - Gross Cost

Plant and equipment

305,929 GBP2024-09-30

153,957 GBP2023-09-30

Computers

2,301 GBP2024-09-30

1,261 GBP2023-09-30

Property, Plant & Equipment - Gross Cost

308,230 GBP2024-09-30

155,218 GBP2023-09-30

Property, Plant & Equipment - Accumulated Depreciation & Impairment

Plant and equipment

99,579 GBP2024-09-30

26,631 GBP2023-09-30

Computers

839 GBP2024-09-30

245 GBP2023-09-30

Property, Plant & Equipment - Accumulated Depreciation & Impairment

100,418 GBP2024-09-30

26,876 GBP2023-09-30

Property, Plant & Equipment - Increase From Depreciation Charge for Year

Plant and equipment

72,948 GBP2023-10-01 ~ 2024-09-30

Computers

594 GBP2023-10-01 ~ 2024-09-30

Property, Plant & Equipment - Increase From Depreciation Charge for Year

73,542 GBP2023-10-01 ~ 2024-09-30

Property, Plant & Equipment

Plant and equipment

206,350 GBP2024-09-30

127,326 GBP2023-09-30

Computers

1,462 GBP2024-09-30

1,016 GBP2023-09-30

Trade Debtors/Trade Receivables

Current, Amounts falling due within one year

20,405 GBP2024-09-30

22,371 GBP2023-09-30

Other Debtors

Current, Amounts falling due within one year

267,698 GBP2024-09-30

153,997 GBP2023-09-30

Debtors

Current, Amounts falling due within one year

288,103 GBP2024-09-30

176,368 GBP2023-09-30

Trade Creditors/Trade Payables

Current

16,139 GBP2024-09-30

33,782 GBP2023-09-30

Other Creditors

Current

317,352 GBP2024-09-30

120,543 GBP2023-09-30

Non-current

3,147,619 GBP2024-09-30

2,918,141 GBP2023-09-30

Number of Shares Issued (Fully Paid)

Class 1 ordinary share

600,000 shares2024-09-30

Class 2 ordinary share

200,000 shares2024-09-30

Profit/Loss

Retained earnings (accumulated losses)

-1,507,535 GBP2023-10-01 ~ 2024-09-30

Profit/Loss

-1,507,535 GBP2023-10-01 ~ 2024-09-30

SWARM ONCOLOGY LIMITED
Info
Registered number 14372453
15 Stukeley Street (c/o Delin Ventures), London WC2B 5LT
PRIVATE LIMITED COMPANY incorporated on 2022-09-23 (3 years 3 months). The company status is Active.
The last date of confirmation statement was made at 2024-09-22
CIF 0

Offspring entities and appointments

Active 0

Not found in our database.